{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:37:26Z","timestamp":1794875846549,"version":"4.9.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.heliyon.2023.e19226","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T08:16:52Z","timestamp":1692346612000},"page":"e19226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Improved survival of SARS COV-2-infected K18-hACE2 mice treated with adenosine A2AR agonist"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5549-2562","authenticated-orcid":false,"given":"Barbara J.","family":"Mann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Chhabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savannah G.","family":"Brovero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riley T.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2731-3299","authenticated-orcid":false,"given":"Jeffrey M.","family":"Sturek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5045-6725","authenticated-orcid":false,"given":"Marieke K.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7874-0090","authenticated-orcid":false,"given":"Joel","family":"Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"Brayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e19226_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106054","article-title":"Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies","volume":"56","author":"Sharma","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.heliyon.2023.e19226_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V\u2019kovski","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.heliyon.2023.e19226_bib3","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3390\/biomedicines9101373","article-title":"Extracellular Vesicle-based therapy for COVID-19: promises, challenges and future prospects","volume":"9","author":"Karn","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.heliyon.2023.e19226_bib4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.heliyon.2023.e19226_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2020.100618","article-title":"COVID-19 and multiorgan response","volume":"45","author":"Zaim","year":"2020","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e19226_bib6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e19226_bib7","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/cid\/ciab536","article-title":"Improved survival among hospitalized patients with coronavirus disease 2019 (COVID-19) treated with remdesivir and dexamethasone. A nationwide population-based cohort study","volume":"73","author":"Benfield","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2023.e19226_bib8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus remdesivir for hospitalized adults with covid-19","volume":"384","author":"Kalil","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e19226_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.752227","article-title":"Beyond vaccines: clinical status of prospective COVID-19 therapeutics","volume":"12","author":"Kumar","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2023.e19226_bib10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2174\/157339912803529878","article-title":"The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation","volume":"8","author":"Chhabra","year":"2012","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.heliyon.2023.e19226_bib11","article-title":"Adenosine-A2A receptor pathway in cancer immunotherapy","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2023.e19226_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239692","article-title":"Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia","volume":"15","author":"Correale","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e19226_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.676577","article-title":"Case report: can inhaled adenosine attenuate COVID-19?","volume":"12","author":"Spiess","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e19226_bib14","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1371\/journal.pbio.0030174","article-title":"Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury","volume":"3","author":"Thiel","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.heliyon.2023.e19226_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0014-2999(02)01305-5","article-title":"Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat","volume":"438","author":"Fozard","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e19226_bib16","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.4049\/jimmunol.179.2.1254","article-title":"Therapeutic anti-inflammatory effects of myeloid cell adenosine receptor A2a stimulation in lipopolysaccharide-induced lung injury","volume":"179","author":"Reutershan","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2023.e19226_bib17","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.nuclcard.2007.06.114","article-title":"Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial","volume":"14","author":"Iskandrian","year":"2007","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e19226_bib18","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1086\/386311","article-title":"A 2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis","volume":"189","author":"Sullivan","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.heliyon.2023.e19226_bib19","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.orthres.2005.01.015","article-title":"An adenosine A2A receptor agonist reduces interleukin-8 expression and glycosaminoglycan loss following septic arthrosis","volume":"23","author":"Cohen","year":"2005","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.heliyon.2023.e19226_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jss.2007.08.008","article-title":"Adenosine A2A activation attenuates nontransplantation lung reperfusion injury","volume":"149","author":"Ellman","year":"2008","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.heliyon.2023.e19226_bib21","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.healun.2020.02.003","article-title":"Adenosine A2A receptor agonist (regadenoson) in human lung transplantation","volume":"39","author":"Lau","year":"2020","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.heliyon.2023.e19226_bib22","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.4269\/ajtmh.20-0762","article-title":"Evaluation of K18-hACE2 mice as a model of SARS-CoV-2 infection","volume":"103","author":"Moreau","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.heliyon.2023.e19226_bib23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.heliyon.2023.e19226_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.heliyon.2023.e19226_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009195","article-title":"K18-hACE2 mice develop respiratory disease resembling severe COVID-19","volume":"17","author":"Yinda","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.heliyon.2023.e19226_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00819-21","article-title":"Infectious clones produce SARS-CoV-2 that causes severe pulmonary disease in infected K18-human ACE2 mice","volume":"12","author":"Liu","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.heliyon.2023.e19226_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009195","article-title":"K18-hACE2 mice develop respiratory disease resembling severe COVID-19","volume":"17","author":"Yinda","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.heliyon.2023.e19226_bib29","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","article-title":"SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function","volume":"21","author":"Winkler","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.heliyon.2023.e19226_bib30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2174\/157339912803529878","article-title":"The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation","volume":"8","author":"Chhabra","year":"2012","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.heliyon.2023.e19226_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s10020-020-00230-x","article-title":"IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19","volume":"26","author":"Chen","year":"2020","journal-title":"Mol Med"},{"key":"10.1016\/j.heliyon.2023.e19226_bib32","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.4049\/jimmunol.2100294","article-title":"Comprehensive immunologic evaluation of bronchoalveolar lavage samples from human patients with moderate and severe seasonal influenza and severe COVID-19","volume":"207","author":"Reynolds","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2023.e19226_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.840757","article-title":"Heterogeneous infectivity and pathogenesis of SARS-CoV-2 variants beta, delta and omicron in transgenic K18-hACE2 and wildtype mice","volume":"13","author":"Tarr\u00e9s-Freixas","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.heliyon.2023.e19226_bib34","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/JVI.02012-06","article-title":"Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus","volume":"81","author":"McCray","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.heliyon.2023.e19226_bib35","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1182\/blood-2010-06-290643","article-title":"Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease","volume":"116","author":"Wallace","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2023.e19226_bib36","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"key":"10.1016\/j.heliyon.2023.e19226_bib37","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v082.i13","article-title":"lmerTest package: tests in linear mixed effects models","volume":"82","author":"Kuznetsova","year":"2017","journal-title":"J Stat Softw"},{"key":"10.1016\/j.heliyon.2023.e19226_bib38","unstructured":"R Core Team, R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria."},{"key":"10.1016\/j.heliyon.2023.e19226_bib39","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1165\/rcmb.2009-0210ST","article-title":"An official American thoracic society workshop report: features and measurements of experimental acute lung injury in animals","volume":"44","author":"Matute-Bello","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023064344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023064344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:26:56Z","timestamp":1783114016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023064344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2405844023064344"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19226","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved survival of SARS COV-2-infected K18-hACE2 mice treated with adenosine A2AR agonist","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e19226"}}